Sandoz Announces Key Leadership Changes

Sandoz Group AG has unveiled significant leadership shifts aimed at bolstering its strategic objectives. Pascal Bouye steps in as President of Generics Manufacturing & Supply, marking his entry into the Sandoz Executive Committee. With a background at Danone and Mars, he is set to enhance the efficiency of Sandoz's generics operations. Glenn Gerecke, the departing leader, will remain within the company in a new role.

Meanwhile, North America President Keren Haruvi will now spearhead the company's global M&A activities. Her experience from Novartis fortifies her role in shaping Sandoz's strategic direction. Also, Simon Goeller is appointed as Country President for Germany, with these changes effective from August.

CEO Richard Saynor emphasized the importance of these appointments in leveraging Sandoz's leadership depth, especially during a period of significant market opportunities. This realignment is designed to expand access to affordable, high-quality medications.